<DOC>
	<DOCNO>NCT02334722</DOCNO>
	<brief_summary>The purpose study see difference patient receive Levetiracetam extended-release tablet one week surgery remove brain tumor versus receive Levetiracetam extended-release tablet six week surgery . Specifically , see one group less side effect , whether one group seizures .</brief_summary>
	<brief_title>1 Week Versus 6 Weeks Levetiracetam Surgical Brain Tumor Patients</brief_title>
	<detailed_description>Because seizures one lead neurologic complication brain tumor patient , neurosurgeon prescribe antiepileptic drug ( AEDs ) help prevent . Although American Academy Neurology ( AAN ) guideline recommend AEDs stop first post-operative week patient without seizure , standard length treatment patient may stay AEDs indefinitely . In attempt develop clinical guideline AED use post-operative brain tumor patient , try determine take levetiracetam extended-release ( Keppra XR ) 1 week result less neurotoxicity take 6 week .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Adult ( &gt; 18 year age old ) patient undergone surgical resection biopsy supratentorial brain tumor able consent . Able randomized prior 48 hour surgery . No known history seizure activity . Pregnant breastfeeding . Renal dysfunction ( CrCl &lt; 30ml/min ) . Beck 's Depression Inventory ( BDI ) â‰¥11 Allergy levetiracetam .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>